OMEPRAZOLE IS MORE EFFECTIVE THAN CIMETIDINE FOR THE RELIEF OF ALL GRADES OF GASTROESOPHAGEAL REFLUX DISEASE-ASSOCIATED HEARTBURN, IRRESPECTIVE OF THE PRESENCE OR ABSENCE OF ENDOSCOPIC ESOPHAGITIS

Citation
Cm. Bate et al., OMEPRAZOLE IS MORE EFFECTIVE THAN CIMETIDINE FOR THE RELIEF OF ALL GRADES OF GASTROESOPHAGEAL REFLUX DISEASE-ASSOCIATED HEARTBURN, IRRESPECTIVE OF THE PRESENCE OR ABSENCE OF ENDOSCOPIC ESOPHAGITIS, Alimentary pharmacology & therapeutics, 11(4), 1997, pp. 755-763
Citations number
13
Categorie Soggetti
Pharmacology & Pharmacy","Gastroenterology & Hepatology
ISSN journal
02692813
Volume
11
Issue
4
Year of publication
1997
Pages
755 - 763
Database
ISI
SICI code
0269-2813(1997)11:4<755:OIMETC>2.0.ZU;2-2
Abstract
Background: Previous studies have demonstrated greater efficacy for om eprazole compared with cimetidine in patients with endoscopically veri fied oesophagitis, but excluded the substantial group of gastro-oesoph ageal reflux disease (GERD) patients with reflux symptoms but without endoscopic abnormality. This prospective, randomized, double-blind stu dy compared omeprazole and cimetidine in the treatment of GERD-associa ted heartburn both in patients with symptomatic nonulcerative oesophag itis and in those with heartburn but without oesophagitis. Methods: A total of 221 patients with heartburn and oesophageal mucosa grade 0 (n ormal, n = 51), 1 (no macroscopic erosions, n = 52), 2 (isolated erosi ons, n = 97) or 3 (confluent erosions, n = 21) were randomized to rece ive double-blind either omeprazole 20 mg daily or cimetidine 400 mg q. d.s. for a period of 4 weeks. Those still symptomatic after 4 weeks of treatment received omeprazole 20 mg daily for a further 4 weeks. Resu lts: There was no correlation between severity of heartburn and endosc opic grade at entry (correlation coefficient = 0.196). After 4 weeks o f treatment, the proportion of patients in whom heartburn was controll ed (no more than mild symptoms on no more than 1 day in the previous 7 ) on omeprazole (66%; 74/112) was more than double that on cimetidine (31%; 34/109) (P < 0.0001). There was no significant difference betwee n the relief of heartburn in the 47% of patients without unequivocal o esophagitis (endoscopic grade 0 or 1) and in the 53% of patients with erosive oesophagitis (grade 2 or 3) (P = 0.31). Only treatment with om eprazole (P < 0.0001) and lower severity of heartburn at entry (P < 0. 01) were significant in predicting heartburn relief. Amongst those pat ients requiring an additional 4 weeks of treatment with omeprazole, 67 % (54/81) reported that their heartburn was controlled after 8 weeks o f treatment. Conclusion: We conclude that omeprazole is superior to ci metidine for the relief of all grades of heartburn in GERD, whether or not the patient has unequivocal endoscopic oesophagitis.